Pulmonx Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Pulmonx Corporation (LUNG)
US:NASDAQ Investor Relations:
investor.prolunginc.com/investor-relations
Company Research
Source: Yahoo! Finance
the “Company”), a global leader in minimally invasive treatments for lung disease, today reported financial results for the quarter ended March 31, 2024. Recent Highlights Recorded worldwide revenue of $18.9 million in the first quarter of 2024, a 30% increase over the same period last year and an increase of 29% on a constant currency basis Delivered $12.9 million in U.S. revenue in the first quarter of 2024, representing 38% year-over-year growth Realized gross margin of 75% in the first quarter of 2024 Treated first patient with the AeriSeal ® System in CONVERT II pivotal clinical trial Treated first patient in Japanese post-approval study with Zephyr ® Valves Appointed Steve Williamson as President and Chief Executive Officer and Mehul Joshi as Chief Financial Officer “We are pleased with our first quarter performance as we continued to see traction with our commercial strategy,” said Steve Williamson, President and Chief Executive Officer. “My early experience at
Show less
Read more
Impact Snapshot
Event Time:
LUNG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LUNG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LUNG alerts
High impacting Pulmonx Corporation news events
Weekly update
A roundup of the hottest topics
LUNG
News
- Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High? [Yahoo! Finance]Yahoo! Finance
- Earnings Update: Pulmonx Corporation (NASDAQ:LUNG) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts [Yahoo! Finance]Yahoo! Finance
- Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
LUNG
Earnings
- 5/1/24 - Beat
LUNG
Sec Filings
- 5/7/24 - Form 4
- 5/3/24 - Form S-8
- 5/3/24 - Form 10-Q
- LUNG's page on the SEC website